ELECTROPHYSIOLOGICAL EFFECTS OF SEROTONIN IN THE SOLITARY TRACT NUCLEUS OF THE RAT

被引:17
作者
FELDMAN, PD
机构
[1] Department of Pharmacology and Experimental Therapeutics, Louisiana State University Medical Center, New Orleans, 70112-1393, LA
关键词
AUTONOMIC; BRAIN SLICE; ELECTROPHYSIOLOGY; SEROTONIN; SOLITARIUS;
D O I
10.1007/BF00169132
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The nucleus tractus solitarius (nTS) is an important site for the integration of visceral information and its modification by afferent neural systems. One such afferent system arises from the raphe nuclei. This study investigated the electrophysiological effects of the primary transmitter of the raphe nuclei, serotonin (5-HT), on neurones in the nTS of the rat. Extracellular single unit recordings were made of the spontaneous activity of nTS neurones in isolated, superfused brainstem slices during bath-application of 5-HT (50, 100, 250, 500, 1000 nM). Twenty-seven of 46 neurones studied (-similar to 9%) showed concentration-dependent decreases of firing rate, with a calculated EC(50) of 261 nM. An additional 3 neurones displayed excitatory responses, while the remaining 16 were unaffected. The broad-spectrum 5-HT1 antagonist methysergide (200 nM) was highly effective in producing blockade of 5-HT-evoked depressions of neuronal activity (4 of 4), whereas the 5-HT1A receptor-selective antagonist spiroxatrine (5 nM) and the 5-HT2-selective antagonist mianserin (200 nM) were considerably less effective (1 of 5 and 2 of 5, respectively). Seven additional neurones were examined during exposure to the 5-HT1-selective agonist 5-carboxamidotryptamine (5-CT) or the 5-HT2-selective agonist DOI. 5-CT depressed the activity of three of the four neurones tested, the remaining neurone being unresponsive at concentrations up to 50 nM. DOI at concentrations up to 100 nM failed to affect the activity of two of the three neurones tested, and depressed the activity of the third at a concentration of 50 nM. These data provide electrophysiological evidence of the presence of 5-HT, serotonergic receptors in the nTS, and suggest that 5-HT primarily has a depressent effect on the activity of individual neurones in the nTS.
引用
收藏
页码:447 / 454
页数:8
相关论文
共 58 条
[1]   CLONING OF ANOTHER HUMAN SEROTONIN RECEPTOR (5-HT1F) - A 5TH 5-HT1 RECEPTOR SUBTYPE COUPLED TO THE INHIBITION OF ADENYLATE-CYCLASE [J].
ADHAM, N ;
KAO, HT ;
SCHECHTER, LE ;
BARD, J ;
OLSEN, M ;
URQUHART, D ;
DURKIN, M ;
HARTIG, PR ;
WEINSHANK, RL ;
BRANCHEK, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) :408-412
[2]  
APPEL NM, 1990, J PHARMACOL EXP THER, V255, P843
[3]   BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF THE SEROTONIN (5-HT)1A-RECEPTOR LIGAND SPIROXATRINE [J].
BARRETT, JE ;
HOFFMANN, SM ;
OLMSTEAD, SN ;
FOUST, MJ ;
HARROD, C ;
WEISSMAN, BA .
PSYCHOPHARMACOLOGY, 1989, 97 (03) :319-325
[4]   RAPHE NUCLEI OF CAT BRAIN-STEM - TOPOGRAPHICAL ATLAS OF THEIR EFFERENT PROJECTIONS AS REVEALED BY AUTORADIOGRAPHY [J].
BOBILLIER, P ;
SEGUIN, S ;
PETITJEAN, F ;
SALVERT, D ;
TOURET, M ;
JOUVET, M .
BRAIN RESEARCH, 1976, 113 (03) :449-486
[5]   PRESENCE OF 5-HT-POSITIVE NEURONS IN THE MEDIAL NUCLEI OF THE SOLITARY TRACT [J].
CALZA, L ;
GIARDINO, L ;
GRIMALDI, R ;
RIGOLI, M ;
STEINBUSCH, HWM ;
TIENGO, M .
BRAIN RESEARCH, 1985, 347 (01) :135-139
[6]   CARDIORESPIRATORY ACTIONS OF SUBSTANCE-P, TRH AND 5-HT IN THE NUCLEUS TRACTUS SOLITARIUS OF RATS - EVIDENCE FOR FUNCTIONAL INTERACTIONS OF NEUROPEPTIDES AND AMINE NEUROTRANSMITTERS [J].
CARTER, DA ;
LIGHTMAN, SL .
NEUROPEPTIDES, 1985, 6 (05) :425-436
[7]   EVIDENCE FOR EXCITATORY 5-HT2-RECEPTORS ON RAT BRAIN-STEM NEURONS [J].
DAVIES, M ;
WILKINSON, LS ;
ROBERTS, MHT .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (02) :483-491
[8]  
DEDEOGLU A, 1991, J PHARMACOL EXP THER, V257, P425
[9]  
DEDEOGLU A, 1991, J PHARMACOL EXP THER, V259, P1027
[10]   THE 5-HT4 RECEPTOR SUBTYPE INHIBITS K+ CURRENT IN COLLICULI NEURONS VIA ACTIVATION OF A CYCLIC AMP-DEPENDENT PROTEIN-KINASE [J].
FAGNI, L ;
DUMUIS, A ;
SEBBEN, M ;
BOCKAERT, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (04) :973-979